Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-23-000050
Filing Date
2023-08-03
Accepted
2023-08-03 16:34:34
Documents
92
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230630x10q.htm   iXBRL 10-Q 2643039
2 EX-10.1 tmb-20230630xex10d1.htm EX-10.1 50902
3 EX-31.1 tmb-20230630xex31d1.htm EX-31.1 10919
4 EX-31.2 tmb-20230630xex31d2.htm EX-31.2 10730
5 EX-32.1 tmb-20230630xex32d1.htm EX-32.1 5930
6 EX-32.2 tmb-20230630xex32d2.htm EX-32.2 6125
  Complete submission text file 0001070081-23-000050.txt   13047957

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20230630.xsd EX-101.SCH 79493
8 EX-101.CAL tmb-20230630_cal.xml EX-101.CAL 75805
9 EX-101.DEF tmb-20230630_def.xml EX-101.DEF 405081
10 EX-101.LAB tmb-20230630_lab.xml EX-101.LAB 768156
11 EX-101.PRE tmb-20230630_pre.xml EX-101.PRE 620952
85 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230630x10q_htm.xml XML 2664251
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 231140669
SIC: 2834 Pharmaceutical Preparations